Literature DB >> 17549767

Iron-mediated degradation kinetics of substituted dispiro-1,2,4-trioxolane antimalarials.

Darren J Creek1, William N Charman, Francis C K Chiu, Richard J Prankerd, Kevin J McCullough, Yuxiang Dong, Jonathan L Vennerstrom, Susan A Charman.   

Abstract

The iron-mediated reactivity of various dispiro-1,2,4-trioxolanes was determined by automated kinetic analysis under standard reaction conditions. The active antimalarial compounds underwent peroxide bond cleavage by Fe(II) resulting in products indicative of carbon-centered radical formation. The rate of reaction was heavily influenced by the presence of spiro-substituted adamantane and cyclohexane rings, and was also significantly affected by cyclohexane ring substitution. Steric hindrance around the peroxide oxygen atoms appeared to be the major determinant of reaction rate, however polar substituents also affected reactivity by an independent mechanism. A wide range of reaction rates was observed within this class of peroxide antimalarials, however iron-mediated reactivity did not directly correlate with in vitro antimalarial activity. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17549767     DOI: 10.1002/jps.20958

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  24 in total

1.  Antimalarial Trioxolanes with Superior Drug-Like Properties and In Vivo Efficacy.

Authors:  Brian R Blank; Ryan L Gonciarz; Poulami Talukder; Jiri Gut; Jennifer Legac; Philip J Rosenthal; Adam R Renslo
Journal:  ACS Infect Dis       Date:  2020-05-18       Impact factor: 5.084

Review 2.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

3.  In vivo bioluminescence imaging of labile iron accumulation in a murine model of Acinetobacter baumannii infection.

Authors:  Allegra T Aron; Marie C Heffern; Zachery R Lonergan; Mark N Vander Wal; Brian R Blank; Benjamin Spangler; Yaofang Zhang; Hyo Min Park; Andreas Stahl; Adam R Renslo; Eric P Skaar; Christopher J Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-14       Impact factor: 11.205

4.  Drug delivery to the malaria parasite using an arterolane-like scaffold.

Authors:  Shaun D Fontaine; Benjamin Spangler; Jiri Gut; Erica M W Lauterwasser; Philip J Rosenthal; Adam R Renslo
Journal:  ChemMedChem       Date:  2014-10-14       Impact factor: 3.466

Review 5.  Activity-based sensing fluorescent probes for iron in biological systems.

Authors:  Allegra T Aron; Audrey G Reeves; Christopher J Chang
Journal:  Curr Opin Chem Biol       Date:  2018-01-05       Impact factor: 8.822

6.  Parasite-Mediated Degradation of Synthetic Ozonide Antimalarials Impacts In Vitro Antimalarial Activity.

Authors:  Susan A Charman; Darren J Creek; Carlo Giannangelo; Lukas Stingelin; Tuo Yang; Leann Tilley
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

7.  Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Anna Leonidova; Mireille Vargas; Jörg Huwyler; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

8.  Comparative antimalarial activities of six pairs of 1,2,4,5-tetraoxanes (peroxide dimers) and 1,2,4,5,7,8-hexaoxonanes (peroxide trimers).

Authors:  Yuxiang Dong; Darren Creek; Jacques Chollet; Hugues Matile; Susan A Charman; Sergio Wittlin; James K Wood; Jonathan L Vennerstrom
Journal:  Antimicrob Agents Chemother       Date:  2007-05-07       Impact factor: 5.191

9.  Stability of peroxide antimalarials in the presence of human hemoglobin.

Authors:  Darren J Creek; Eileen Ryan; William N Charman; Francis C K Chiu; Richard J Prankerd; Jonathan L Vennerstrom; Susan A Charman
Journal:  Antimicrob Agents Chemother       Date:  2009-06-01       Impact factor: 5.191

10.  Ferrous iron-dependent drug delivery enables controlled and selective release of therapeutic agents in vivo.

Authors:  Edgar Deu; Ingrid T Chen; Erica M W Lauterwasser; Juan Valderramos; Hao Li; Laura E Edgington; Adam R Renslo; Matthew Bogyo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.